Jim Simons Oragenics Inc Transaction History

Renaissance Technologies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.11 - $15.59 $6,214 - $880,803	56,498 Added 24.36%	288,398 $30,000
Q3 2022 Nov 14, 2022	BUY	$0.23 - $14.18 $5,129 - $316,214	22,300 Added 10.64%	231,900 $53,000
Q2 2022 Aug 12, 2022	BUY	$0.24 - $0.42 $27,072 - $47,376	112,800 Added 116.53%	209,600 $73,000
Q1 2022 May 13, 2022	BUY	$0.33 - $0.56 $25,410 - $43,120	77,000 Added 388.89%	96,800 $33,000
Q4 2021 Feb 11, 2022	SELL	$0.43 - $0.69 $375,994 - $603,339	-874,405 Reduced 97.79%	19,800 $9,000
Q3 2021 Nov 12, 2021	BUY	$0.58 - $0.84 $372,151 - $538,978	641,641 Added 254.05%	894,205 $568,000
Q2 2021 Aug 13, 2021	BUY	$0.6 - $0.89 $151,538 - $224,781	252,564 New	252,564 $178,000
Q4 2020 Feb 10, 2021	SELL	$0.39 - $0.6 $314,722 - $484,188	-806,980 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$0.56 - $1.49 $311,541 - $828,922	556,324 Added 221.95%	806,980 $464,000
Q2 2020 Aug 13, 2020	BUY	$0.39 - $0.83 $97,755 - $208,044	250,656 New	250,656 $174,000
Q1 2020 May 14, 2020	SELL	$0.43 - $0.75 $62,393 - $108,825	-145,100 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.42 - $0.62 $60,942 - $89,962	145,100 New	145,100 $76,000
Q3 2019 Nov 13, 2019	SELL	$0.36 - $0.64 $19,393 - $34,476	-53,870 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$0.46 - $0.6 $24,780 - $32,322	53,870 New	53,870 $26,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $41.9M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.